Treatment of Prostate Cancer In Israel - Therapy of Extraclass

Prostate or prostate cancer is currently an intimidating disease for the male population. The disease is called one of the most common causes of death of elderly men.

Unambiguous provocation of the development of this disease is not established. The likelihood of being among patients with this diagnosis is increasing with age, also in the presence of cases of disease in immediate relatives. The development of prostate cancer is associated with the appearance of an exchange imbalance in the organs of a man - an increase in the level of testosterone - a male hormone.

Factors of the disease include progressive prostate adenoma, sexually transmitted viruses, poor nutrition with a preference for animal fat fats, harmful enterprises associated with cadmium (printing and welding, manufacturing of rubber products). Among the factors that contribute to the progression of prostate cancer, doctors identify smoking, polluted ecology and also weather conditions. For one reason, a lower temperature and a drier climate provoke the incidence of this type of oncology. This predisposition is noticed in the lack of vitamin D, found in patients from the coldest edges.

The malignancy of prostate cancer lies in the inconspicuous progression and metastasis of the tumor in the body of a man. At the stage of a small amount of education and also the presence of pre-tumor changes, it is realistic to suspect the disease is due to the increase in the blood environment of the concentration of the prostatic characteristic antigen (PSA).

The most striking symptoms of the disease usually become noticeable at far-reaching stages. It is necessary to attract attention due to difficulty with urination, difficultly restrained and frequent at night signals to urinate, urinary incontinence.

The development of metastases and deterioration of the lymphatic drain predisposes to swelling of the lower parts of the body, the scrotum, the penis. The development of the tumor increases the problems with stool, painful defecation. Metastatic formations in bone tissue provoke pain in the joints of the pelvis, lower parts of the body, the lumbar region. Metastases can also affect other primary organs of the man, they include the lungs, the liver organ, the adrenal glands.

Timely detection of prostate cancer in Israel is considered the key to successful treatment. Therefore, frequent diagnostic tests are needed from a urologist. Palpation of the prostate gland is capable of detecting the compaction of the prostate, and they must be checked for malignancy of the formation. To this end, use the analysis of the level of PSA in blood cells - a substance whose level during prostate cancer rises sharply. Clarify the diagnosis with a rectal EC scan of the prostate (TRUS). The search for metastatic formations is carried out using magnetic resonance imaging and also PET-CT, an innovative technology that combines the types of instruments - positron emission tomography and CT. This method diagnoses the location of microscopic tumors.

The presence of metastatic formations in bone tissue is detected using isotope scanning of bones.

The most important and correct way to confirm the diagnosis of prostate cancer in Israel is to perform a prostate biopsy. To this end, using a control ultrasound in the prostate gland by the rectal method, a special needle is inserted to collect the organ tissue specimen and the subsequent histological examination.

The data obtained in the course of studies on the presence of prostate cancer, data on its malignancy and the extent of the spread of metastases determine the choice of treatment regimen.

Treatment of prostate cancer in Israel implies an individual approach to any therapeutic case, taking into account the research data, the patient's age and his preferences.

Among the treatment options use constant observation, surgery, laser and chemotherapy, hormonal therapy.

An active examination of patients with prostate cancer detected provides for the timely analysis and control of PSA levels without treatment until a symptom of the disease or a serious increase in PSA is detected.

The main method of treating patients with localized prostate cancer in Israel is radical prostatectomy - surgical excision of the prostate and cancer cells from adjacent areas. The operation is performed by laparoscopic methods of surgery and also with the help of the automated system "Da Vinci".

As an analogue of radical prostatectomy, transurethral resection of the prostate gland is used, when a region of the prostate blocking the urine stream is removed through the urethra. This therapy is indicated by cancer patients who, because of advanced age or other complex diseases, can not resort to radical prostatectomy.

Radiation therapy in the treatment of prostate cancer in Israel by powerful radiation - outside or internal (brachytherapy) - kills tumor cells, reduces the area of the hearth and prevents its development.

Drug treatment of prostate cancer in Israel means taking hormones that reduce or localize testosterone.

Chemotherapy is usually used for progressive prostate cancer and a lack of response to hormonal therapy.

Treatment of prostate cancer in Israel means, if possible, the preservation of erectile function, a system of rehabilitation measures to strengthen the muscles of the bottom of the hip bone.